메뉴 건너뛰기




Volumn , Issue , 2007, Pages 356-368

Growth hormone treatment in skeletal dysplasias: The KIGS experience

Author keywords

[No Author keywords available]

Indexed keywords


EID: 67749085217     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101867     Document Type: Chapter
Times cited : (5)

References (39)
  • 3
    • 50549219325 scopus 로고
    • Long-term treatment of hypopitu-itary and of achondroplastic dwarfism with human growth hormone
    • Gershberg H, Mari S, Hulse M, St Paul H: Long-term treatment of hypopitu-itary and of achondroplastic dwarfism with human growth hormone. Metabo-lism 1964;13:152-160.
    • (1964) Metabo-lism , vol.13 , pp. 152-160
    • Gershberg, H.1    Mari, S.2    Hulse, M.3    St Paul, H.4
  • 7
    • 0346749736 scopus 로고    scopus 로고
    • Skeletal dysplasia, growth hormone treatment and body proportions: comparison with other syndromic and non-syndromic short children
    • Hagenäs L, Hertel T: Skeletal dysplasia, growth hormone treatment and body proportions: comparison with other syndromic and non-syndromic short children. Horm Res 2003;60:65-70.
    • (2003) Horm Res , vol.60 , pp. 65-70
    • Hagenäs, L.1    Hertel, T.2
  • 8
    • 1842848098 scopus 로고    scopus 로고
    • Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism
    • Horton WA, Lunstrum GP: Fibroblast growth factor receptor 3 mutations in achondroplasia and related forms of dwarfism. Rev Endocr Metab Disord 2002;3:381-385.
    • (2002) Rev Endocr Metab Disord , vol.3 , pp. 381-385
    • Horton, W.A.1    Lunstrum, G.P.2
  • 10
    • 0037097976 scopus 로고    scopus 로고
    • FGF signaling pathways in endochondral and intra-membranous bone development and human genetic disease
    • Ornitz DM, Marie PJ: FGF signaling pathways in endochondral and intra-membranous bone development and human genetic disease. Genes Dev 2002;16:1446-1465.
    • (2002) Genes Dev , vol.16 , pp. 1446-1465
    • Ornitz, D.M.1    Marie, P.J.2
  • 15
    • 0037296350 scopus 로고    scopus 로고
    • The comparison of the ef-fects of short-term growth hormone treatment in patients with achondro-plasia and with hypochondroplasia
    • Tanaka N, Katsumata N, Horikawa R, Tanaka T: The comparison of the ef-fects of short-term growth hormone treatment in patients with achondro-plasia and with hypochondroplasia. Endocr J 2003;50:69-75.
    • (2003) Endocr J , vol.50 , pp. 69-75
    • Tanaka, N.1    Katsumata, N.2    Horikawa, R.3    Tanaka, T.4
  • 18
    • 33751330697 scopus 로고    scopus 로고
    • Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia
    • Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J: Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet 2006;14:1240-1247.
    • (2006) Eur J Hum Genet , vol.14 , pp. 1240-1247
    • Heuertz, S.1    Le Merrer, M.2    Zabel, B.3    Wright, M.4    Legeai-Mallet, L.5    Cormier-Daire, V.6    Gibbs, L.7    Bonaventure, J.8
  • 22
    • 0025975265 scopus 로고
    • Growth characteristics and response to growth hormone therapy in patients with hy-pochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients
    • Mullis PE, Patel MS, Brickell PM, Hindmarsh PC, Brook CGD: Growth characteristics and response to growth hormone therapy in patients with hy-pochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients. Clin Endo-crinol 1991;34:265-274.
    • (1991) Clin Endo-crinol , vol.34 , pp. 265-274
    • Mullis, P.E.1    Patel, M.S.2    Brickell, P.M.3    Hindmarsh, P.C.4    Brook, C.G.D.5
  • 24
    • 20944436622 scopus 로고    scopus 로고
    • Dis-proportionate stature but normal height in hypochondroplasia
    • Riepe FG, Krone N, Sippell WG: Dis-proportionate stature but normal height in hypochondroplasia. Eur J Pe-diatr 2005;164:397-399.
    • (2005) Eur J Pe-diatr , vol.164 , pp. 397-399
    • Riepe, F.G.1    Krone, N.2    Sippell, W.G.3
  • 25
    • 0026316869 scopus 로고
    • Growth of children with hypochondro-plasia treated with growth hormone for up to three years
    • Bridges NA, Hindmarsh P, Brook CGD: Growth of children with hypochondro-plasia treated with growth hormone for up to three years. Horm Res 1991;36(suppl 1):56-60.
    • (1991) Horm Res , vol.36 , Issue.SUPPL. 1 , pp. 56-60
    • Bridges, N.A.1    Hindmarsh, P.2    Brook, C.G.D.3
  • 33
    • 0032888428 scopus 로고    scopus 로고
    • SHOX: pseudoautosomal ho-meobox containing gene for short stat-ure and dyschondrosteosis
    • Ogata T: SHOX: pseudoautosomal ho-meobox containing gene for short stat-ure and dyschondrosteosis. Growth Horm IGF Res 1999;9(suppl B):53-57.
    • (1999) Growth Horm IGF Res , Issue.SUPPL. B , pp. 53-57
    • Ogata, T.1
  • 34
    • 0036908813 scopus 로고    scopus 로고
    • SHOX haploinsufficiency and its modifying factors
    • Ogata T: SHOX haploinsufficiency and its modifying factors. J Pediatr Endo-crinol Metab 2002;15(suppl 5):1289-1294.
    • (2002) J Pediatr Endo-crinol Metab , vol.15 , Issue.SUPPL. 5 , pp. 1289-1294
    • Ogata, T.1
  • 39
    • 0029952406 scopus 로고    scopus 로고
    • Natural history study of pseudoachondroplasia
    • McKeand J, Rotta J, Hecht JT: Natural history study of pseudoachondroplasia. Am J Med Genet 1996;63:406-410.
    • (1996) Am J Med Genet , vol.63 , pp. 406-410
    • McKeand, J.1    Rotta, J.2    Hecht, J.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.